A multicenter study of prognostic factors of renal cell carcinoma: survival analysis based on follow-up over 5 years
张进,王共先,郭剑明,齐隽,朱冶华,陈勇辉,薛蔚,刘东明,黄翼然
DOI: https://doi.org/10.3760/cma.j.issn.1000-6702.2015.02.009
2015-01-01
Abstract:Objective To analyze long-term survival of renal cell carcinoma (RCC) after surgery and its prognostic factors.Methods A total of 1 544 non-metastatic RCCs who underwent surgery from 2000 to 2008 in 4 medical centers in China were enrolled.The long-term survival information as well as possible prognostic factors,including age,sex,tumor histologic subtype,grading,staging,lymph node metastasis,type of surgery,etc.,were collected and analyzed.Results Of all the 1 544 patients,1 041 were male and 503 were female.The average size of lesion was 5.4±3.1 cm,with median at 4.7 cm.Histologic subtype was clear cell RCC in 1 371 (88.8％),papillary in 89 (5.8％),chromophobe in 44 (2.8％),collecting duct in 4 (0.3％) and other subtypes in 36 (2.3％).Fuhrman grading was Ⅰ in 322 (24.8％),Ⅱ in 791 (60.8％),Ⅲ in 168 (12.9％) and Ⅳ in 20 (1.5％).Tumor staging according to 2010 AJCC TNM staging system was pT1 in 1 162 (75.3％),pT2 in 247 (16.0％),pT3 in 103 (6.7％) and pT4 in 24 (1.6％).Lymph node metastasis was negative in 1 491 (96.6％),positive in 53 (3.4％).The overall follow-up rate was 93.4％ with a median follow-up time of 59.8±23.3 months.The 1-year,3-year and 5-year overall survival rate was 98.2％,93.4％ and 89.4％.There was no significant difference among the three main histologic subtypes (P=0.935).The 5-year overall survival for clear cell,papillary and chromophobe RCC was 90.1％,85.8％ and 89.6％,respectively.The 5-year overall survival for Fuhrman Ⅰ to Ⅳ was 93.6％,91.1％,84.2％ and 36.5％,respectively.The 5-year overall survival for pT1,pT2,pT3 and pT4 was 93.5％,84.5％,60.7％ and 70.0％,respectively.Patients with no lymph node metastasis had a 5-year overall survival of 91.3％,significantly higher than that of patients with lymph node metastasis (37.1％).Fuhrman grading,T staging and lymph node metastasis were significant prognostic factors in Log-rank test.In the multivariate analysis,age ≥ 55 years,high grade (Fuhrman Ⅲ-Ⅳ) tumors,tumor size,tumor staging over T3 and lymph node metastasis were independent prognostic factors,while sex,side of tumor and type of surgery were not.Conclusion In non-metastatic RCC receiving surgical therapy,age,tumor size,grading,staging and lymph node metastasis are independent prognostic factors for 5-year overall survival.